Market Trends Sandoz launches biosimilar Pyzchiva in U.S. for all approved Stelara indicationsBy admin8996erT0allFebruary 24, 2025 Sandoz (OTCQX:SDZNY) Monday said that Pyzchiva (ustekinumab-ttwe) is now commercially available to patients across the U.S. Developed by Samsung Bioepis…
